DY Lu, RX Qu, TR Lu, HY Wu - Reviews on recent clinical trials, 2017 - ingentaconnect.com
Background: Last two to three decades, this world witnesses a rapid progress of biomarkers
and bioinformatics technologies. Cancer bioinformatics is one of such important omics …